Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study

NCT05602974 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Narrow Margin
Adjuvant Stereotactic Body Radiotherapy
Hepatectomy

Interventions

RADIATION: stereotactic body radiation therapy
OTHER: regular follow-up

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University